CapForce, Inc. (CFOR)
6.02
-0.88
(-12.75%)
USD |
OTCM |
Nov 05, 16:00
CapForce Price to Book Value : 1.005 for Nov. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 1.005 |
| November 04, 2026 | 1.152 |
| November 03, 2026 | 1.628 |
| November 02, 2026 | 1.628 |
| October 30, 2026 | 1.628 |
| October 29, 2026 | 1.502 |
| October 28, 2026 | 1.419 |
| October 27, 2026 | 1.502 |
| October 26, 2026 | 0.6743 |
| October 23, 2026 | 0.6743 |
| October 22, 2026 | 0.661 |
| October 21, 2026 | 0.6727 |
| October 20, 2026 | 0.6727 |
| October 19, 2026 | 0.6727 |
| October 16, 2026 | 0.5842 |
| October 15, 2026 | 0.6743 |
| October 14, 2026 | 0.6743 |
| October 13, 2026 | 0.6615 |
| October 12, 2026 | 0.6667 |
| October 09, 2026 | 0.6667 |
| October 08, 2026 | 0.662 |
| October 07, 2026 | 0.676 |
| October 06, 2026 | 0.6743 |
| October 05, 2026 | 0.676 |
| October 02, 2026 | 0.676 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.6743 |
| September 30, 2026 | 0.6743 |
| September 29, 2026 | 0.6743 |
| September 28, 2026 | 0.651 |
| September 25, 2026 | 0.6743 |
| September 24, 2026 | 0.6743 |
| September 23, 2026 | 0.6743 |
| September 22, 2026 | 0.5554 |
| September 21, 2026 | 0.5341 |
| September 18, 2026 | 0.5809 |
| September 17, 2026 | 0.5809 |
| September 16, 2026 | 0.5809 |
| September 15, 2026 | 0.5091 |
| September 14, 2026 | 0.6343 |
| September 11, 2026 | 0.7094 |
| September 10, 2026 | 0.768 |
| September 09, 2026 | 0.768 |
| September 08, 2026 | 0.8596 |
| September 04, 2026 | 0.8596 |
| September 03, 2026 | 0.8596 |
| September 02, 2026 | 0.8596 |
| September 01, 2026 | 0.8596 |
| August 31, 2026 | 0.8596 |
| August 28, 2026 | 0.8598 |
| August 27, 2026 | 0.8598 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Phio Pharmaceuticals Corp. | 0.7449 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.28 |
| Anika Therapeutics, Inc. | 1.638 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 1.129 |
| PS Ratio | 0.8797 |
| PEG Ratio | 0.0058 |
| Price to Free Cash Flow | 2.358 |
| Price | 6.02 |
| Earnings Yield | 88.56% |
| Market Cap | 74.64M |
| PEGY Ratio | 0.0058 |
| Operating PE Ratio | 1.037 |
| Normalized PE Ratio | 1.129 |